An unusual neuroimaging finding and response to immunotherapy in a child with genetically confirmed vanishing white matter disease

European Journal of Paediatric Neurology

Volumn 21, Issue 2, 2017, Pages 410-413

  Singh, Rahul Raman ^a   Livingston, John ^b   Lim, Ming ^a   Berry, Ian R ^c   Siddiqui, Ata ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cranial nerve enhancement; EIF mutation; Immunotherapy; Leukodystrophy; Vanishing white matter disease

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; STEROID;

ACUTE BRAIN DISEASE; ARTICLE; ATAXIA; BRAIN EDEMA; BRAIN STEM; CASE REPORT; CHILD; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; CORTICOSTEROID THERAPY; CRANIAL NEUROPATHY; DIFFUSION WEIGHTED IMAGING; ELECTROENCEPHALOGRAM; FEMALE; FOLLOW UP; GASTROENTERITIS; GENETIC SCREENING; HEMISPHERE; HETEROZYGOSITY; HUMAN; IMMUNOTHERAPY; LEUKODYSTROPHY; LUMBAR PUNCTURE; METACHROMATIC LEUKODYSTROPHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PYRAMIDAL TRACT; SANGER SEQUENCING; SPINAL ROOT; TREATMENT RESPONSE; TRIGEMINAL NERVE; VANISHING WHITE MATTER DISEASE; WHITE MATTER; WHITE MATTER LESION; BRAIN DISEASES; COMPLICATION; DRUG EFFECTS; EDEMA; GENETICS; IMMUNOLOGY; PATHOLOGY;

ADRENAL CORTEX HORMONES; BRAIN DISEASES; BRAIN STEM; CHILD, PRESCHOOL; EDEMA; FEMALE; GENETIC TESTING; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; WHITE MATTER;

EID: 84994531547     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2016.08.012     Document Type: Article

References (8)

1. 1 Schiffmann, R, Fogli, A, Van der Knaap, MS and Boespflug-Tanguy, O. Childhood ataxia with central nervous system hypomyelination/vanishing white matter. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. Gene Review [Updated 2012 Aug 09].
2. 2 Van der Knaap, M.S., Pronk, J.C., Scheper, G.C., Vanishing white matter disease. Lancet Neurol 5 (2006), 413–423.
3. 3 Ohlenbusch, A., Henneke, M., Brockmann, K., et al. Identification of ten novel mutations in patients with eIF2B-related disorders. Hum Mutat, 25, 2005, 411.
4. 4 Fogli, A., Schiffmann, R., Bertini, E., et al. The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology, 62, 2004 1509–15173.
5. 5 Van der Lei, H.W., Steenweg, M.E., Bugiani, M., et al. Restricted diffusion in vanishing white matter. Arch Neurol 69:6 (2012), 723–727.
6. 6 Vasconcellos, E., Smith, M., MRI nerve root enhancement in Krabbe disease. Pediatr Neurol 19 (1998), 151–152.
7. 7 Maia, A.C., da Rocha, A.J., da Silva, C.J., et al. Multiple cranial nerve enhancement: a new MR imaging finding in metachromatic leukodystrophy. Am J Neuroradiol, 28, 2007 999–999.
8. 8 Eichler, F., Van Haren, K., Immune response in leukodystrophies. Pediatr Neurol 37 (2007), 235–244.